Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Trump administration issues proposal for drug importation plan

The Trump administration, along with HHS and the FDA, have issued a notice of proposed rulemaking (NRPM) for a drug importation plan to allow certain drugs to be purchased from Canada.

Thumbnail

3 key requirements for AI in healthcare to reach its full potential

AI could change healthcare forever. But for the technology to reach its full potential, researchers must make sure they go about things the right way.

Thumbnail

The role of medical debt in American bankruptcy

Medical debt is a significant factor in the reasons Americans file for bankruptcy, and Americans facing major health scares are also likely to face financial setbacks.

Thumbnail

Justice Department sues CVS subsidiary Omnicare

A CVS Health subsidiary, Omnicare, is facing a lawsuit from the Department of Justice over allegations the company defrauded government health programs by providing prescription drugs to thousands of long-term care facilities without proper prescriptions.

Thumbnail

HHS proposals aim to boost organ donation supply

HHS has issued a set of two proposed rules aimed at improving the availability of organs for the 113,000 Americans on waitlists for transplants.

Thumbnail

Humana acquiring hospice pharmacy Enclara Healthcare

Louisville-based Humana, the nation’s third-largest health insurance provider, is acquiring a large privately held hospice pharmacy and benefit management providers, Enclara Healthcare.

Thumbnail

Top 10 healthiest states in America

Vermont is ranked as the nation’s healthiest state, according to UnitedHealth Group, which released its annual population health rankings. Mississippi trails the country as the least healthy state in the nation.

Thumbnail

Digital health pharma deals reach new high in 2019

Seeking to accelerate technological capabilities, healthcare investors have been snapping up AI and machine learning companies and driving up digital health M&A in the pharmaceutical and biotechnology space as a result.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup